EBGLYSS

Google image searchProduct monograph

Active ingredient

lebrikizumab, 250 MG/2 ML

DIN: 02549123

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: PREFILLED PEN

Schedule: Prescription / Schedule D

Company: ELI LILLY CANADA INC

Date: 19-SEP-2024

ATC:

• L04 — (ATC, ATC/DDD, )
• L04 — (ATC, ATC/DDD)
• L04 — (ATC, ATC/DDD)

External Links for Ebglyss

Search on Google

• Ebglyss side effects
• Ebglyss dosage
• lebrikizumab side effects
• lebrikizumab dosage

Eli Lilly Canada Inc

Go to Eli Lilly website to see drug product details. Sometimes you can find ebglyss photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.